News

Pictilisib plus fulvestrant boosts PFS in ER/PR+ patients

Publish date: December 10, 2014

 

AT SABCS 2014

References

msullivan@frontlinemedcom.com

Pages

Recommended Reading

‘Chemo brain’ may have targetable causes
MDedge Hematology and Oncology
Breast cancer margins, radiotherapy, axillary dissection evolve
MDedge Hematology and Oncology
Meditation, yoga earn high marks as supportive care during breast cancer treatment
MDedge Hematology and Oncology
VIDEO: An easy way to improve breast biopsy practices
MDedge Hematology and Oncology
A round-up of ASCO’s 2013-2014 guideline releases, updates, and endorsements
MDedge Hematology and Oncology
Mastectomies, reconstruction, on the rise for women with early stage disease
MDedge Hematology and Oncology
Breast cancer relapse risk halved since 1986
MDedge Hematology and Oncology
Too many elderly with breast cancer still receive radiotherapy
MDedge Hematology and Oncology
SABCS 2014: Dr. Hope S. Rugo gives her top picks
MDedge Hematology and Oncology
Ultrasound screening for dense breasts is high cost, offers little benefit
MDedge Hematology and Oncology